Fentanyl: Clinical Trials

3 trials for Fentanyl, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 not yet recruiting. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Not yet recruiting 3

Follow Fentanyl: new trials by email Literature Review of Fentanyl trials Research Report on Fentanyl

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Outpatient Treatment Retention Among Individuals Using Fentanyl Randomized to Low-dose and Direct-to-inject Buprenorphine Initiation
Injectable buprenorphine, Sublingual Buprenorphine (SUBOXONE, Zubsolv, or generic tablets) - Opioid Use Disorder, Fentanyl
Phase 4Not yet recruitingUniversity of California, San Francisco502026-06-012026-03-13
D-FAB-POUR Trial: Dexmedetomidine vs Fentanyl as Adjuvants to Bupivacaine on Postoperative Urinary Retention
Intervention 1: Intrathecal Dexmedetomidine with Bupivacaine, Intervention 2: Intrathecal Fentanyl with Bupivacaine - Spinal Anesthesia, Postoperative Complications
Phase 4Not yet recruitingTribhuvan University Teaching Hospital, Institute Of Medicine.1902025-09-152025-08-12
Comparative Study Between Intrathecal Magnesium Sulfate, Neostigmine and Fentanyl as Adjuvant for Bubivacaine in Postoperative Analgesia in Lower Abdominal Surgeries
Magnesium Sulfate and Bupivacaine 0.125%, bupivacaine and Neostigmine, fentanyl and bupivacaine - Magnesium Sulfate, Neostigmine
Phase 4Not yet recruitingAssiut University662024-12-012024-11-12

Narrower conditions

Opioid-Related Disorders (1)  ·  Postoperative Complications (1)

Broader conditions

Chemically-Induced Disorders (1)  ·  Mental Disorders (1)  ·  Narcotic-Related Disorders (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Substance-Related Disorders (1)

Interventions

Bupivacaine (2)  ·  Buprenorphine (1)  ·  Buprenorphine, Naloxone Drug Combination (1)  ·  Fentanyl (1)  ·  Magnesium Sulfate (1)  ·  Neostigmine (1)  ·  Sublocade (1)

Sponsors

Assiut University (1)  ·  Tribhuvan University Teaching Hospital, Institute Of Medicine. (1)  ·  University of California, San Francisco (1)

Countries

Nepal (1)  ·  United States (1)

Top investigators

Leslie W Suen, MD (1)

Results publications

PMID 27746548, PMID 29284839, PMID 30622224, PMID 31362883, PMID 32024465, PMID 35016456, PMID 35803751, PMID 37601044, PMID 38429736

NIH funding

K23DA060329 (1)